Vertex Pharmaceuticals (VRTX) awards 99.941 deferred stock units to director
Rhea-AI Filing Summary
SACHS BRUCE I reported acquisition or exercise transactions in this Form 4 filing.
Vertex Pharmaceuticals director Bruce I. Sachs received a grant of 99.941 deferred stock units on July 15, 2026 at $475.28 per unit. Each unit represents one share of common stock, payable upon his board service ending, a change of control, disability, or death, bringing his directly held deferred stock units to 15,771.807.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SACHS BRUCE I
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 99.941 | $475.28 | $47K |
Holdings After Transaction:
Deferred Stock Units — 15,771.807 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Deferred stock units granted: 99.941 units
Grant price per unit: $475.2800
Deferred stock units after grant: 15,771.807 units
+2 more
5 metrics
Deferred stock units granted
99.941 units
Grant to director Bruce I. Sachs on July 15, 2026
Grant price per unit
$475.2800
Price per Deferred Stock Unit for the July 15, 2026 award
Deferred stock units after grant
15,771.807 units
Directly held Deferred Stock Units by Bruce I. Sachs following the transaction
Underlying common shares per unit
1 share
Each deferred stock unit represents one share of Vertex common stock
Underlying common shares for grant
99.941 shares
Common stock underlying the 99.941 Deferred Stock Units granted
Key Terms
Deferred Stock Units, change of control, board of directors
3 terms
Deferred Stock Units financial
"Each deferred stock unit represents one share of common stock and is paid out in common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
change of control financial
"upon the earliest to occur of termination of service, a change of control of our company"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
board of directors financial
"termination of Mr. Sachs' service on our board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity award did Vertex Pharmaceuticals (VRTX) report for Bruce I. Sachs?
Vertex reported that director Bruce I. Sachs received a grant of 99.941 deferred stock units on July 15, 2026 at $475.28 per unit, each representing one share of common stock settled at specified future events.
How many deferred stock units does Bruce I. Sachs now hold at Vertex Pharmaceuticals (VRTX)?
Following the reported grant, Bruce I. Sachs directly holds 15,771.807 deferred stock units. Each deferred stock unit is tied to one share of Vertex common stock and will be paid out in shares when specified service or control events occur.
When will Bruce I. Sachs’s deferred stock units at Vertex (VRTX) be paid out?
The deferred stock units are paid in Vertex common stock upon the earliest of his board service ending, a change of control of the company, or his disability or death, as specified in the footnote to the award.
What type of security was granted to Bruce I. Sachs in the Vertex (VRTX) Form 4?
Bruce I. Sachs received Deferred Stock Units, a derivative security where each unit corresponds to one share of Vertex common stock. The award reflects director compensation rather than an open-market purchase or sale of common shares.
Was the Bruce I. Sachs Vertex (VRTX) Form 4 transaction a market buy or sell?
No. The Form 4 shows an acquisition coded as a grant of Deferred Stock Units, not a market purchase or sale. It represents equity compensation, leaving his directly held deferred stock unit balance at 15,771.807 following the award.